Trademark: 97760175
Word
REVUFORJ
Status
Pending
Status Code
730
Status Date
Friday, July 12, 2024
Serial Number
97760175
Mark Type
4
Filing Date
Thursday, January 19, 2023
Published for Opposition
Tuesday, November 28, 2023
Trademark Owner History
Syndax Pharmaceuticals, Inc. - Owner At Publication
Classifications
5 Pharmaceutical preparations for the treatment of cancer
44 Providing information in the field of cancer treatment; providing links to the web sites of others featuring information about the diagnosis and treatment of cancer
42 Research and development of pharmaceuticals for the treatment of cancer; medical and scientific research services in the field of cancer treatment
Trademark Events
Jan 23, 2023
New Application Entered
Feb 8, 2023
New Application Office Supplied Data Entered
Oct 17, 2023
Assigned To Examiner
Oct 20, 2023
Approved For Pub - Principal Register
Nov 8, 2023
Notification Of Notice Of Publication E-Mailed
Nov 28, 2023
Published For Opposition
Nov 28, 2023
Official Gazette Publication Confirmation E-Mailed
Jan 23, 2024
Noa E-Mailed - Sou Required From Applicant
Jul 12, 2024
Sou Teas Extension Received
Jul 12, 2024
Notice Of Approval Of Extension Request E-Mailed
Jul 12, 2024
Sou Extension 1 Filed
Jul 12, 2024
Sou Extension 1 Granted
TAYNREVU
REJVEDI
Trademark Alertz updated from USPTO on 2030-01-24

Trademark Alertz ™ - Twit Solutions PTY LTD 2024 - Privacy Policy - Terms of Use

The information provided on Trademark Alertz is not legal or professional advice. Information may have been obtained from third parties and may contain errors. You must make your own enquiries and seek independent advice from relevant industry professionals before acting or relying on any information from Trademark Alertz. All trade mark information has been obtained from and made publicly available by The United States Patent and Trademark Office (USPTO). Copyright of the trademark data resides with USPTO. www.uspto.gov